Cabozantinib is undoubtedly an oral multikinase inhibitor permitted to the therapy of Superior renal mobile carcinoma. Radiological response evaluation could be tough since, like other multikinase inhibitors, cabozantinib leads to vascularization reduction and, in the lung, it may be connected with metastasis cavitation rather than a pure sizing re